BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 29787966)

  • 1. Injection drug use, HIV/HCV, and related services in nonurban areas of the United States: A systematic review.
    Paquette CE; Pollini RA
    Drug Alcohol Depend; 2018 Jul; 188():239-250. PubMed ID: 29787966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in sources and sharing of needles among people who inject drugs, San Francisco, 2005-2012.
    Kim NJ; Jin H; McFarland W; Raymond HF
    Int J Drug Policy; 2015 Dec; 26(12):1238-43. PubMed ID: 26365768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention knowledge, risk behaviours and seroprevalence among nonurban injectors of southwest Connecticut.
    Grau LE; Zhan W; Heimer R
    Drug Alcohol Rev; 2016 Sep; 35(5):628-36. PubMed ID: 27073014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of spatial proximity to fixed-site syringe services programs with HCV serostatus and injection equipment sharing practices among people who inject drugs in rural New England, United States.
    Romo E; Stopka TJ; Jesdale BM; Wang B; Mazor KM; Friedmann PD
    Harm Reduct J; 2024 Jan; 21(1):23. PubMed ID: 38282000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and risk factors associated with HIV/hepatitis B and HIV/hepatitis C co-infections among people who inject drugs in Mozambique.
    Semá Baltazar C; Boothe M; Kellogg T; Ricardo P; Sathane I; Fazito E; Raymond HF; Temmerman M; Luchters S
    BMC Public Health; 2020 Jun; 20(1):851. PubMed ID: 32493347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HCV serostatus and injection sharing practices among those who obtain syringes from pharmacies and directly and indirectly from syringe services programs in rural New England.
    Romo E; Rudolph AE; Stopka TJ; Wang B; Jesdale BM; Friedmann PD
    Addict Sci Clin Pract; 2023 Jan; 18(1):2. PubMed ID: 36597153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-border injection drug use and HIV and hepatitis C virus seropositivity among people who inject drugs in San Diego, California.
    Horyniak D; Wagner KD; Armenta RF; Cuevas-Mota J; Hendrickson E; Garfein RS
    Int J Drug Policy; 2017 Sep; 47():9-17. PubMed ID: 28683432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review.
    Degenhardt L; Peacock A; Colledge S; Leung J; Grebely J; Vickerman P; Stone J; Cunningham EB; Trickey A; Dumchev K; Lynskey M; Griffiths P; Mattick RP; Hickman M; Larney S
    Lancet Glob Health; 2017 Dec; 5(12):e1192-e1207. PubMed ID: 29074409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Syringe Service Programs for Persons Who Inject Drugs in Urban, Suburban, and Rural Areas - United States, 2013.
    Des Jarlais DC; Nugent A; Solberg A; Feelemyer J; Mermin J; Holtzman D
    MMWR Morb Mortal Wkly Rep; 2015 Dec; 64(48):1337-41. PubMed ID: 26655918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baseline prevalence and correlates of HIV and HCV infection among people who inject drugs accessing a syringe services program; Miami, FL.
    Bartholomew TS; Onugha J; Bullock C; Scaramutti C; Patel H; Forrest DW; Feaster DJ; Tookes HE
    Harm Reduct J; 2020 Jun; 17(1):40. PubMed ID: 32522201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of co-occurring mental health problems with hepatitis C status among young people who inject drugs in rural New Mexico, 2016-2018.
    Gupta A; Shebl FM; Tong Y; Wagner K; Bassett IV; Page K; Winstanley EL
    Addict Sci Clin Pract; 2022 Oct; 17(1):58. PubMed ID: 36266666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding hepatitis B, hepatitis C and HIV among people who inject drugs in South Africa: findings from a three-city cross-sectional survey.
    Scheibe A; Young K; Moses L; Basson RL; Versfeld A; Spearman CW; Sonderup MW; Prabdial-Sing N; Manamela J; Puren AJ; Rebe K; Hausler H
    Harm Reduct J; 2019 Apr; 16(1):28. PubMed ID: 30975139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of needle and syringe Programmes in people who inject drugs - An overview of systematic reviews.
    Fernandes RM; Cary M; Duarte G; Jesus G; Alarcão J; Torre C; Costa S; Costa J; Carneiro AV
    BMC Public Health; 2017 Apr; 17(1):309. PubMed ID: 28399843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlates of anti-hepatitis C positivity and use of harm reduction services among people who inject drugs in two cities in Croatia.
    Handanagic S; Sevic S; Barbaric J; Dominkovic Z; Dakovic Rode O; Begovac J; Bozicevic I
    Drug Alcohol Depend; 2017 Feb; 171():132-139. PubMed ID: 28088084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vital Signs: Trends in HIV Diagnoses, Risk Behaviors, and Prevention Among Persons Who Inject Drugs - United States.
    Wejnert C; Hess KL; Hall HI; Van Handel M; Hayes D; Fulton P; An Q; Koenig LJ; Prejean J; Valleroy LA
    MMWR Morb Mortal Wkly Rep; 2016 Dec; 65(47):1336-1342. PubMed ID: 27906906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homelessness, unstable housing, and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis.
    Arum C; Fraser H; Artenie AA; Bivegete S; Trickey A; Alary M; Astemborski J; Iversen J; Lim AG; MacGregor L; Morris M; Ong JJ; Platt L; Sack-Davis R; van Santen DK; Solomon SS; Sypsa V; Valencia J; Van Den Boom W; Walker JG; Ward Z; Stone J; Vickerman P;
    Lancet Public Health; 2021 May; 6(5):e309-e323. PubMed ID: 33780656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential access to syringe exchange and other prevention activities among people who inject drugs in rural and urban areas of Puerto Rico.
    Welch-Lazoritz M; Habecker P; Dombrowski K; Rivera Villegas A; Davila CA; Rolón Colón Y; Miranda De León S
    Int J Drug Policy; 2017 May; 43():16-22. PubMed ID: 28160735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scaling-up HCV prevention and treatment interventions in rural United States-model projections for tackling an increasing epidemic.
    Fraser H; Zibbell J; Hoerger T; Hariri S; Vellozzi C; Martin NK; Kral AH; Hickman M; Ward JW; Vickerman P
    Addiction; 2018 Jan; 113(1):173-182. PubMed ID: 28734093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-Risk Injection-Related Practices Associated with anti-HCV Positivity among Young Adults Seeking Services in Three Small Cities in Wisconsin.
    Rogers-Brown J; Sublett F; Canary L; Rein DB; Bhat M; Thompson WW; Vellozzi C; Asher A
    Subst Use Misuse; 2022; 57(5):665-673. PubMed ID: 35240921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Injection risk norms and practices among migrant Puerto Rican people who inject drugs in New York City: The limits of acculturation theory.
    Gelpí-Acosta C; Guarino H; Benoit E; Deren S; Pouget ER; Rodríguez A
    Int J Drug Policy; 2019 Jul; 69():60-69. PubMed ID: 31196730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.